Every material Form 8-K SiriusPoint filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
SiriusPoint reported third-quarter 2026 net income available to common shareholders of $87 million, or $0.74 per diluted share, and operating earnings per share of $0.88, up 19%. The company also agreed to a loss portfolio transfer with RiverStone covering substantially all remaining run-off reserves, which it expects to unlock over $200 million of capital, subject to regulatory approval. Core combined ratio worsened to 90.1% from 89.1% a year earlier.
Q3 net income available to common shareholders of $87 million, or $0.74 per diluted share, versus $86.8 million a year earlier
Operating EPS of $0.88 versus $0.74 in Q3 2025; nine-month diluted EPS of $2.14 versus $1.71
Core gross written premium up 13.7% to $990.6 million; core combined ratio 90.1% versus 89.1%
RiverStone loss portfolio transfer is subject to regulatory approval and expected to unlock over $200 million of capital; webcast set for November 6, 2026 at 8:30 a.m. ET
SiriusPoint Ltd. announced that John Sauerland, a former Progressive Insurance Chief Financial Officer with more than 35 years of insurance industry experience, will join its Board of Directors effective January 1, 2027. The Board has determined he is independent and an audit committee financial expert, and he will receive the same director compensation as the company's other non-employee directors.
Appointment effective January 1, 2027, as a Class I director with a term running until the 2029 annual general meeting of shareholders
Previously served as Chief Financial Officer at Progressive Insurance and has more than 35 years of insurance industry experience
Board determined he is independent under NYSE and Exchange Act requirements and qualifies as an audit committee financial expert
No committee appointments yet; the company will file an amendment to this Form 8-K when they are determined
SiriusPoint reported second-quarter 2026 net income available to common shareholders of $69 million, or $0.58 per diluted share, compared with $0.50 a year earlier. Consolidated underwriting income fell to $73.5 million from $90.2 million, and the core combined ratio rose to 91.4% from 89.5%, while half-year net income rose 44% to $168 million. The company has repurchased $95 million of common shares so far in 2026 as of July 28, 2026, and the filing gives no updated guidance.
Q2 2026 diluted EPS of $0.58 vs. $0.50 in Q2 2025; operating EPS of $0.67 vs. $0.66
Core combined ratio of 91.4% vs. 89.5% a year earlier; Q2 total revenues of $744.1 million vs. $748.2 million
Half-year 2026 net income of $168 million, up 44%; operating EPS of $1.37, up 17%
Book value per diluted share excluding AOCI rose 3% from March 31, 2026 to $19.48
SiriusPoint reported first-quarter 2026 results, with net income available to common shareholders of $99.6 million, or $0.82 per diluted share, compared with $57.6 million a year earlier. Operating earnings per share rose 37% to $0.70, and the Core combined ratio improved to 88.9% from 95.4%, driven mainly by lower catastrophe losses. The company also increased its 2026 share repurchase commitment by $74 million to $174 million.
Net income available to common shareholders of $99.6 million ($0.82 diluted EPS) versus $57.6 million in Q1 2025
Operating EPS of $0.70 versus $0.51, up 37%; annualized return on equity 17.4% versus 12.9%
Core combined ratio 88.9% versus 95.4%; catastrophe losses of $5.4 million versus $67.9 million
Net written premium fell 7.3% to $696.8 million; net investment income fell to $66.4 million from $71.2 million
SiriusPoint Ltd. appointed Sabra R. Purtill to its Board of Directors effective March 25, 2026, and the Board confirmed that Franklin (Tad) Montross IV and Peter W. H. Tan will not stand for reelection at the 2026 annual general meeting. The filing says Ms. Purtill has been named to the Audit Committee and Risk & Capital Management Committee and that the Board considers her an independent director and an audit committee financial expert.
Sabra R. Purtill, 63, appointed to the Board effective March 25, 2026, as a Class I director with 40 years of insurance and financial services experience.
Ms. Purtill joins the Audit Committee and Risk & Capital Management Committee.
Franklin (Tad) Montross IV, Risk & Capital Management Committee Chair, and Peter W. H. Tan will leave the Board and their committee roles immediately after the annual general meeting on May 20, 2026.
The filing states the two departures are not the result of any disagreement with the Company.
SiriusPoint International, a subsidiary of SiriusPoint Ltd., signed a Settlement Agreement with its President and CEO Rob Gibbs on March 17, 2026, in connection with his departure. The severance package is 401,700 GBP, paid in 12 monthly installments after his last day of employment on April 30, 2026, and the company will also cover some medical and life assurance costs into 2027.
Rob Gibbs, President & CEO of SiriusPoint International, is departing; his last day of employment is April 30, 2026.
Severance is 401,700 GBP, paid in 12 equal monthly installments, and includes payment in lieu of his six-month notice period.
Gibbs will not receive a bonus for 2025, and medical coverage is to continue through April 30, 2027.
The settlement includes a general release of claims and ongoing confidentiality, non-compete, and non-solicitation obligations.
SiriusPoint announced on March 16, 2026 that it will operate through four business areas, combining its North America and International Programs businesses into a Global P&C Programs division and creating a London Market Specialty division. As part of the changes, Rob Gibbs, President & CEO of SiriusPoint International, will leave the company, with the separation date and severance terms still being finalized. The filing gives no financial results or guidance, and the company said there will be no changes to its Global Reinsurance and Global Accident & Health businesses.
Four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty, which includes Lloyd's
Global P&C Programs will be led by Patrick Charles; London Market Specialty will be led by David Govrin, President
Rob Gibbs, President & CEO of SiriusPoint International, is leaving; the separation date and agreement are still being finalized
The company will file a further Form 8-K to disclose the separation date once it is set
SiriusPoint reported fourth-quarter 2025 net income available to common shareholders of $240 million, or $1.97 per diluted share, compared with a loss of $21.3 million a year earlier. Total revenues rose to $973.7 million from $612.8 million, and the company intends to repurchase $100 million of common shares over the next 12 months. The Core combined ratio worsened to 92.9% from 90.2%, a secondary measure that slipped.
Q4 2025 net income available to common shareholders was $240 million, or $1.97 per diluted share, versus a loss of $21.3 million ($0.13 per share) in Q4 2024.
Operating earnings per share were $0.70, compared with $0.27 a year earlier; annualized return on equity was 44.9%.
Core combined ratio was 92.9%, compared with 90.2%; gross written premium rose 17.6% to $896.9 million.
The company intends to repurchase $100 million of common shares over the next 12 months and will redeem all 8,000,000 Series B preference shares on February 26, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every SiriusPoint filing is on SEC EDGAR ↗. 8-K briefs of other companies →